{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T05:59:51Z","timestamp":1794549591710,"version":"4.9.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:00:00Z","timestamp":1689552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:00:00Z","timestamp":1689552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Acute myocardial infarction (AMI) can rarely arise from non-lipid-rich coronary plaques. This study sought to compare the clinical outcomes after percutaneous coronary intervention (PCI) between AMI showing maximum lipid-core burden index in 4\u00a0mm (maxLCBI\n                    <jats:sub>4mm<\/jats:sub>\n                    )\u2009&lt;\u2009400 and\u2009\u2265\u2009400 in the infarct-related lesions assessed by near-infrared spectroscopy-intravascular ultrasound (NIRS-IVUS). We investigated 426 AMI patients who underwent NIRS-IVUS in the infarct-related lesions before PCI. Major adverse cardiovascular events (MACE) were defined as the composite of cardiac death, non-fatal MI, clinically driven target lesion revascularization (TLR), clinically driven non-TLR, and congestive heart failure requiring hospitalization. 107 (25%) patients had infarct-related lesions of maxLCBI\n                    <jats:sub>4mm<\/jats:sub>\n                    \u2009&lt;\u2009400, and 319 (75%) patients had those of maxLCBI\n                    <jats:sub>4mm<\/jats:sub>\n                    \u2009\u2265\u2009400. The maxLCBI\n                    <jats:sub>4mm<\/jats:sub>\n                    \u2009&lt;\u2009400 group had a younger median age at onset (68\u00a0years [IQR: 57\u201378\u00a0years] vs. 73\u00a0years [IQR: 64\u201380\u00a0years],\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.007), less frequent multivessel disease (39% vs. 51%,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.029), less frequent TIMI flow grade 0 or 1 before PCI (62% vs. 75%,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.007), and less frequent no-reflow immediately after PCI (5% vs. 11%,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.039). During a median follow-up period of 31\u00a0months [IQR: 19\u201348\u00a0months], the frequency of MACE was significantly lower in the maxLCBI\n                    <jats:sub>4mm<\/jats:sub>\n                    \u2009&lt;\u2009400 group compared with the maxLCBI\n                    <jats:sub>4mm<\/jats:sub>\n                    \u2009\u2265\u2009400 group (4.7% vs. 17.2%,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.001). MaxLCBI\n                    <jats:sub>4mm<\/jats:sub>\n                    \u2009&lt;\u2009400 was an independent predictor of MACE-free survival at multivariable analysis (hazard ratio: 0.36 [confidence interval: 0.13\u20130.98],\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.046). MaxLCBI\n                    <jats:sub>4mm<\/jats:sub>\n                    \u2009&lt;\u2009400 measured by NIRS in the infract-related lesions before PCI was associated with better long-term clinical outcomes in AMI patients.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-38578-9","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T13:02:35Z","timestamp":1689598955000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical outcomes of acute myocardial infarction arising from non-lipid-rich plaque determined by NIRS-IVUS"],"prefix":"10.1038","volume":"13","author":[{"given":"Kosei","family":"Terada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Wakana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Ino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Kh. M.","family":"Khalifa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suwako","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Takahata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutsugu","family":"Shiono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan D.","family":"Madder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeyoshi","family":"Kameyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,17]]},"reference":[{"key":"38578_CR1","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1161\/01.ATV.20.5.1262","volume":"20","author":"R Virmani","year":"2000","unstructured":"Virmani, R., Kolodgie, F. D., Burke, A. P., Farb, A. & Schwartz, S. M. Lessons from sudden coronary death: A comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 20, 1262\u20131275 (2000).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"38578_CR2","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.jcin.2013.04.012","volume":"6","author":"RD Madder","year":"2013","unstructured":"Madder, R. D. et al. Detection by near-infrared spectroscopy of large lipid core plaques at culprit sites in patients with acute ST-segment elevation myocardial infarction. JACC Cardiovasc. Interv. 6, 838\u2013846 (2013).","journal-title":"JACC Cardiovasc. Interv."},{"key":"38578_CR3","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.jcmg.2020.08.030","volume":"14","author":"K Terada","year":"2021","unstructured":"Terada, K. et al. NIRS-IVUS for differentiating coronary plaque rupture, erosion, and calcified nodule in acute myocardial infarction. JACC Cardiovasc. Imaging 14, 1440\u20131450 (2021).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"38578_CR4","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/S0140-6736(19)31794-5","volume":"394","author":"R Waksman","year":"2019","unstructured":"Waksman, R. et al. Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging: A prospective, cohort study. Lancet 394, 1629\u20131637 (2019).","journal-title":"Lancet"},{"key":"38578_CR5","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","volume":"72","author":"K Thygesen","year":"2018","unstructured":"Thygesen, K. et al. Fourth universal definition of myocardial infarction. J. Am. Coll. Cardiol. 72, 2231\u20132264 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"38578_CR6","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1093\/eurheartj\/ehw157","volume":"37","author":"V Sharma","year":"2016","unstructured":"Sharma, V. et al. Myocardial blush and microvascular reperfusion following manual thrombectomy during percutaneous coronary intervention for ST elevation myocardial infarction: Insights from the TOTAL trial. Eur. Heart. J 37, 1891\u20131898 (2016).","journal-title":"Eur. Heart. J"},{"key":"38578_CR7","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1161\/01.CIR.0000072768.80031.74","volume":"107","author":"J Kotani","year":"2003","unstructured":"Kotani, J. et al. Intravascular ultrasound analysis of infarct-related and non-infarct-related arteries in patients who presented with an acute myocardial infarction. Circulation 107, 2889\u20132893 (2003).","journal-title":"Circulation"},{"key":"38578_CR8","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/S0735-1097(01)01175-5","volume":"37","author":"GS Mintz","year":"2001","unstructured":"Mintz, G. S. et al. American college of cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS). A report of the American college of cardiology task force on clinical expert consensus documents. J. Am. Coll. Cardiol. 37, 1478\u20131492 (2001).","journal-title":"J. Am. Coll. Cardiol."},{"key":"38578_CR9","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1161\/01.CIR.101.6.598","volume":"101","author":"P Schoenhagen","year":"2000","unstructured":"Schoenhagen, P. et al. Extent and direction of arterial remodeling in stable versus unstable coronary syndromes: An intravascular ultrasound study. Circulation 101, 598\u2013603 (2000).","journal-title":"Circulation"},{"key":"38578_CR10","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1161\/CIRCULATIONAHA.117.029289","volume":"137","author":"HM Garcia-Garcia","year":"2018","unstructured":"Garcia-Garcia, H. M. et al. Standardized end point definitions for coronary intervention trials: The academic research consortium-2 consensus document. Circulation 137, 2635\u20132650 (2018).","journal-title":"Circulation"},{"key":"38578_CR11","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","volume":"70","author":"CW Yancy","year":"2017","unstructured":"Yancy, C. W. et al. 2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: A report of the American college of cardiology\/American heart association task force on clinical practice guidelines and the heart failure society of America. J. Am. Coll. Cardiol. 70, 776\u2013803 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"38578_CR12","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1016\/j.jcin.2022.08.037","volume":"15","author":"E Usui","year":"2022","unstructured":"Usui, E. et al. Multimodality imaging of possible healed plaque erosion pathologically validated by directional coronary atherectomy specimens. JACC Cardiovasc. Interv. 15, 2225\u20132227 (2022).","journal-title":"JACC Cardiovasc. Interv."},{"key":"38578_CR13","doi-asserted-by":"publisher","first-page":"e999","DOI":"10.4244\/EIJ-D-20-01421","volume":"17","author":"K Terada","year":"2021","unstructured":"Terada, K. et al. Near-infrared spectroscopy to predict microvascular obstruction after primary percutaneous coronary intervention. EuroIntervention 17, e999\u2013e1006 (2021).","journal-title":"EuroIntervention"},{"key":"38578_CR14","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.jcin.2015.02.026","volume":"8","author":"T Higuma","year":"2015","unstructured":"Higuma, T. et al. A combined optical coherence tomography and intravascular ultrasound study on plaque rupture, plaque erosion, and calcified nodule in patients with ST-segment elevation myocardial infarction: Incidence, morphologic characteristics, and outcomes after percutaneous coronary intervention. JACC Cardiovasc. Interv. 8, 1166\u20131176 (2015).","journal-title":"JACC Cardiovasc. Interv."},{"key":"38578_CR15","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1093\/eurheartj\/ehv029","volume":"36","author":"G Niccoli","year":"2015","unstructured":"Niccoli, G. et al. Plaque rupture and intact fibrous cap assessed by optical coherence tomography portend different outcomes in patients with acute coronary syndrome. Eur. Heart J. 36, 1377\u20131384 (2015).","journal-title":"Eur. Heart J."},{"key":"38578_CR16","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.ijcard.2015.11.030","volume":"203","author":"T Yonetsu","year":"2016","unstructured":"Yonetsu, T. et al. Plaque morphologies and the clinical prognosis of acute coronary syndrome caused by lesions with intact fibrous cap diagnosed by optical coherence tomography. Int. J. Cardiol. 203, 766\u2013774 (2016).","journal-title":"Int. J. Cardiol."},{"key":"38578_CR17","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1001\/jama.2022.5218","volume":"327","author":"L R\u00e4ber","year":"2022","unstructured":"R\u00e4ber, L. et al. Effect of alirocumab added to high-intensity statin therapy on coronary atherosclerosis in patients with acute myocardial infarction: The PACMAN-AMI randomized clinical trial. JAMA 327, 1771\u20131781 (2022).","journal-title":"JAMA"},{"key":"38578_CR18","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.jcmg.2022.03.002","volume":"15","author":"SJ Nicholls","year":"2022","unstructured":"Nicholls, S. J. et al. Effect of evolocumab on coronary plaque phenotype and burden in statin-treated patients following myocardial infarction. JACC Cardiovasc. Imaging 15, 1308\u20131321 (2022).","journal-title":"JACC Cardiovasc. Imaging"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38578-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38578-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38578-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T13:02:56Z","timestamp":1689598976000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38578-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,17]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["38578"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-38578-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2295000\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,17]]},"assertion":[{"value":"21 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Madder has received speaker honoraria and research support from Infraredx and serves on the advisory board of SpectraWave. All other authors have no relationships relevant to the contents of this paper to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11544"}}